Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/10/2010 | US20100144594 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors |
06/10/2010 | US20100144593 Pharmaceutical Compositions and Methods for Insulin Treatment |
06/10/2010 | US20100144592 Stable Non-Aqueous Pharmaceutical Compositions |
06/10/2010 | US20100144591 Benzimidazole derivatives and methods of use thereof |
06/10/2010 | US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations |
06/10/2010 | US20100143498 Infusion solution for peripheral intravenous administration |
06/10/2010 | US20100143484 Oral submicron particle delivery system for proteins and process for its production |
06/10/2010 | US20100143474 B-carboline for the treatment of neurodegenerative diseases |
06/10/2010 | US20100143465 Pharmaceutical composition |
06/10/2010 | US20100143460 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
06/10/2010 | US20100143401 Vaccine preventing and/or treating autoimmune diseases |
06/10/2010 | US20100143392 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
06/10/2010 | US20100143385 Methods for reducing phosphate absorption |
06/10/2010 | US20100143383 Oxgr1 agonists for use in therapies for metabolic disorders |
06/10/2010 | US20100143382 Modulation of rhamm (cd168) for selective adipose tissue development |
06/10/2010 | US20100143374 Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
06/10/2010 | US20100143360 Human vascular endothelial growth factor 2 |
06/10/2010 | US20100143349 Humanized anti-rage antibody |
06/10/2010 | US20100143341 Thienopyrimidines for pharmaceutical compositions |
06/10/2010 | US20100143333 Method of treating diabetes |
06/10/2010 | US20100143330 Methods of treating disorders associated with fat storage |
06/10/2010 | US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy |
06/10/2010 | US20100143306 Use of bone marrow cells for long term culture of pancreatic islet cells |
06/10/2010 | US20100143287 Trifluoromethylphenyl modulators of calcium-sensing receptor |
06/10/2010 | US20100143264 Compositions for aerosolization of highly conductive solutions |
06/10/2010 | CA2745721A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators |
06/10/2010 | CA2745527A1 Leptin and leptin analog conjugates and uses thereof |
06/10/2010 | CA2745499A1 Peptide therapeutic conjugates and uses thereof |
06/10/2010 | CA2745433A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof |
06/10/2010 | CA2745420A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0] hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof |
06/10/2010 | CA2745383A1 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders |
06/10/2010 | CA2745356A1 2h-chromene compound and derivative thereof |
06/10/2010 | CA2744985A1 Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia |
06/09/2010 | EP2194064A1 FGF-21 fusion proteins |
06/09/2010 | EP2194062A1 Cyclic heptapeptide and use of the same |
06/09/2010 | EP2194057A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
06/09/2010 | EP2194044A1 Quinolone derivative |
06/09/2010 | EP2194041A1 Novel crystal form IX of atorvastatin hemi-calcium and processes for its preparation |
06/09/2010 | EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
06/09/2010 | EP2192915A1 Therapeutic uses of peptides ysaypdsvpmms and wmnstgftkvcgappc |
06/09/2010 | EP2192889A2 Cosmetic methods and compositions for repairing human skin |
06/09/2010 | EP1711494B1 Aryl substituted heterocycles, method for production and use thereof as medicaments |
06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
06/09/2010 | EP1335907B1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
06/09/2010 | EP1270004B1 Use of gamma-tocotrienol as diuretic |
06/09/2010 | CN1989132B Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
06/09/2010 | CN1956984B 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
06/09/2010 | CN1956711B Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same |
06/09/2010 | CN1935179B Fat-regulating medicinal composition from Tibetanmedicine and its preparing method |
06/09/2010 | CN1882533B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
06/09/2010 | CN1796382B A category of compound of new macrolide, preparation method and application |
06/09/2010 | CN1771239B Vitamin d3 lactone derivatives |
06/09/2010 | CN1662511B Pharmaceutical salts of reboxetine |
06/09/2010 | CN101730529A methods, compounds, and compositions for treating metabolic disorders and diabetes |
06/09/2010 | CN101730475A Body-weight maintenance and body composition |
06/09/2010 | CN101724667A Technology for extracting dendrobium polysaccharide by applying biology engineering enzyme technology and product thereof and application |
06/09/2010 | CN101724622A Method for preparing Lactobacillus casei microcapsule |
06/09/2010 | CN101724589A Method for microencapsulating cholesterol-degrading lactic acid bacteria |
06/09/2010 | CN101724538A Process for producing salvia wine |
06/09/2010 | CN101724075A Remodeling and glycoconjugation of peptides |
06/09/2010 | CN101724026A Melanocortin analogue as well as preparation method and application thereof |
06/09/2010 | CN101724017A 4-nitro-L-phenylalanine dipeptide derivatives as well as preparation method and applications thereof |
06/09/2010 | CN101724015A Alpha-glucosidase inhibitor and preparation method thereof |
06/09/2010 | CN101724007A Oleanolic acid derivatives and application thereof serving as alpha-glucosidase inhibitor |
06/09/2010 | CN101723997A Puerarin glycosylation derivative, medicine compound, preparation method and application thereof |
06/09/2010 | CN101723947A Dipeptidase-IV inhibitor compound |
06/09/2010 | CN101723937A imidazol-4-one and imidazole-4-thione compounds |
06/09/2010 | CN101723921A CaSR antagonist |
06/09/2010 | CN101723857A Lipid prodrug of drug containing guanidino and pharmacosome thereof |
06/09/2010 | CN101721738A High-voltage electrostatic diabetic foot medication film |
06/09/2010 | CN101721712A Double-chain polyethylene glycol-insulin compound and preparation method thereof |
06/09/2010 | CN101721704A Method and medicament for regulating glycogen content in liver cell |
06/09/2010 | CN101721681A Application of human Keratiocyte growth factor 1 in preparation of medicament for treating foot ulcers and leg ulcers of diabetes |
06/09/2010 | CN101721606A medicine for treating diabetes |
06/09/2010 | CN101721593A Medicinal and edible biological composition for improving diabetes and preparation method of capsule thereof |
06/09/2010 | CN101721563A Three high rehabilitation tea |
06/09/2010 | CN101721551A Thrombus-resisting life-prolonging health-care wine prepared by taking gynostemma pentaphylla as main raw material |
06/09/2010 | CN101721546A Extraction of effective components of fruit of Chinese wolfberry and method for preparing sugar-free medicinal granules thereof |
06/09/2010 | CN101721506A Chinese medicinal preparation for removing fat, freeing vessels and nourishing heart |
06/09/2010 | CN101721493A Fat-reducing medicine and preparation method and application thereof |
06/09/2010 | CN101721468A Method for preparing salvianolic acids |
06/09/2010 | CN101721467A Method for preparing total salvianolic acid |
06/09/2010 | CN101721462A Method for harvesting and primarily processing sianchau |
06/09/2010 | CN101721452A New process for improving utilization ratio of lithospermum |
06/09/2010 | CN101721448A Preparation method of silybum marianum total flavonoid as active ingredient of swertia pseudochinensis-silybum marianum liver benefiting product |
06/09/2010 | CN101721446A Method for preparing composite oligosaccharide granules |
06/09/2010 | CN101721432A Giant salamander oil soft capsule, method for preparing same and use thereof |
06/09/2010 | CN101721424A Bicarbonate physiological balanced solution and preparation method thereof |
06/09/2010 | CN101721414A Composition containing pioglitazone hydrochloride and metformin hydrochloride and preparation thereof |
06/09/2010 | CN101721403A Application of fucoxanthin in aspect of losing weight |
06/09/2010 | CN101721388A micro-capsule containing vitamin d3 |
06/09/2010 | CN101721387A Calcium carbonate effervescing agent and preparation method thereof |
06/09/2010 | CN101721369A Method for preparing alpha-lipoic acid liposome |
06/09/2010 | CN101721365A Levulose liposome injection and novel application thereof |
06/09/2010 | CN101721360A Urapidil fructose injection and preparation method thereof |
06/09/2010 | CN101720929A Beverage or oral liquid suitable for diabetes patients |
06/09/2010 | CN101720919A Medlar mulberry hypoglycemic tea |
06/09/2010 | CN101720918A Hawthorn fat reducing tea |
06/09/2010 | CN101720883A Application of xylooligosaccharide used as calcium absorption enhancer |